{"id":"https://openalex.org/W2104958967","doi":"https://doi.org/10.3109/10428190903503438","title":"Osteoblastogenesis and tumor growth in myeloma","display_name":"Osteoblastogenesis and tumor growth in myeloma","alternate_titles":[],"publication_year":2009,"publication_date":"2009-12-29","ids":{"openalex":"https://openalex.org/W2104958967","doi":"https://doi.org/10.3109/10428190903503438","mag":"2104958967","pmid":"https://pubmed.ncbi.nlm.nih.gov/20038269","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2849287"},"language":"en","primary_location":{"id":"doi:10.3109/10428190903503438","doi":"https://doi.org/10.3109/10428190903503438","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428190903503438","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2104958967"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2849287","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039870327","display_name":"Shmuel Yaccoby","orcid":"https://orcid.org/0000-0003-1823-3411","observed_orcids":["https://orcid.org/0000-0003-1823-3411"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shmuel Yaccoby","raw_affiliation_strings":["Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. yaccobyshmuel@uams.edu","Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. yaccobyshmuel@uams.edu","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA","institution_ids":["https://openalex.org/I79620101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039870327"],"corresponding_institution_ids":["https://openalex.org/I79620101"],"apc_list":null,"apc_paid":null,"fwci":0.7793,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.56881464,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"51","issue":"2","first_page":"213","last_page":"220"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11219","display_name":"Bone Metabolism and Diseases","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/osteoblastogenesis","display_name":"osteoblastogenesis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/osteolytic-bone-disease","display_name":"osteolytic bone disease","score":0.7889999747276306},{"id":"https://openalex.org/keywords/osteoclastogenesis","display_name":"osteoclastogenesis","score":0.8650000095367432},{"id":"https://openalex.org/keywords/osteoprogenitor-cells","display_name":"osteoprogenitor cells","score":0.8130000233650208},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9520000219345093},{"id":"https://openalex.org/keywords/bone-formation","display_name":"bone formation","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2778260815","wikidata":"https://www.wikidata.org/wiki/Q917177","display_name":"Osteoblast","level":3,"score":0.8888206481933594},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7717599868774414},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7208523154258728},{"id":"https://openalex.org/C2776033226","wikidata":"https://www.wikidata.org/wiki/Q828410","display_name":"Osteoclast","level":3,"score":0.6919679045677185},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6219912767410278},{"id":"https://openalex.org/C2776169692","wikidata":"https://www.wikidata.org/wiki/Q4941552","display_name":"Bone disease","level":3,"score":0.5221334099769592},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.4302191138267517},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36561769247055054},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36159414052963257},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3523186445236206},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2115669548511505},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.12672698497772217},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07278507947921753},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05444538593292236}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001897","descriptor_name":"Boronic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010006","descriptor_name":"Osteoblasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010006","descriptor_name":"Osteoblasts","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010010","descriptor_name":"Osteoclasts","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010010","descriptor_name":"Osteoclasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010010","descriptor_name":"Osteoclasts","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3109/10428190903503438","doi":"https://doi.org/10.3109/10428190903503438","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428190903503438","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},{"id":"pmid:20038269","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20038269","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:1800284","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2849287","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2849287","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2849287/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Leuk Lymphoma","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:1800284","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2849287","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7730915842","display_name":"Myeloma-Microenvironment Interaction Dynamics","funder_award_id":"R01CA093897","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":88,"referenced_works":["https://openalex.org/W182839316","https://openalex.org/W1522278345","https://openalex.org/W1842497498","https://openalex.org/W1944559787","https://openalex.org/W1965517168","https://openalex.org/W1967125513","https://openalex.org/W1968677875","https://openalex.org/W1973328408","https://openalex.org/W1975549555","https://openalex.org/W1976298275","https://openalex.org/W1979090002","https://openalex.org/W1979193732","https://openalex.org/W1984068295","https://openalex.org/W1985919561","https://openalex.org/W1991753648","https://openalex.org/W1992187858","https://openalex.org/W1992422220","https://openalex.org/W1997688789","https://openalex.org/W1998854709","https://openalex.org/W2000247603","https://openalex.org/W2000655497","https://openalex.org/W2001979983","https://openalex.org/W2002315967","https://openalex.org/W2002918019","https://openalex.org/W2009140393","https://openalex.org/W2009219948","https://openalex.org/W2009275473","https://openalex.org/W2010707503","https://openalex.org/W2012884263","https://openalex.org/W2013187395","https://openalex.org/W2022530652","https://openalex.org/W2023104790","https://openalex.org/W2026387061","https://openalex.org/W2027442509","https://openalex.org/W2031157863","https://openalex.org/W2031812779","https://openalex.org/W2031883266","https://openalex.org/W2036050820","https://openalex.org/W2037109650","https://openalex.org/W2038063884","https://openalex.org/W2038329170","https://openalex.org/W2039215669","https://openalex.org/W2043295936","https://openalex.org/W2044264310","https://openalex.org/W2047202223","https://openalex.org/W2048064990","https://openalex.org/W2048709843","https://openalex.org/W2048981489","https://openalex.org/W2048994674","https://openalex.org/W2051807618","https://openalex.org/W2063355387","https://openalex.org/W2066000727","https://openalex.org/W2066639236","https://openalex.org/W2066758340","https://openalex.org/W2068903854","https://openalex.org/W2071812783","https://openalex.org/W2078400068","https://openalex.org/W2080754894","https://openalex.org/W2089743544","https://openalex.org/W2094541368","https://openalex.org/W2097878023","https://openalex.org/W2102969047","https://openalex.org/W2105159857","https://openalex.org/W2106309343","https://openalex.org/W2106704887","https://openalex.org/W2107648723","https://openalex.org/W2108235071","https://openalex.org/W2108595411","https://openalex.org/W2122038117","https://openalex.org/W2122771799","https://openalex.org/W2123068491","https://openalex.org/W2125347681","https://openalex.org/W2131180956","https://openalex.org/W2139920251","https://openalex.org/W2140945282","https://openalex.org/W2141198813","https://openalex.org/W2144630934","https://openalex.org/W2149248348","https://openalex.org/W2149596047","https://openalex.org/W2163341100","https://openalex.org/W2167629024","https://openalex.org/W2167801466","https://openalex.org/W2167859307","https://openalex.org/W2243623761","https://openalex.org/W2325285113","https://openalex.org/W2406562503","https://openalex.org/W2556388654","https://openalex.org/W3143387670"],"related_works":["https://openalex.org/W2043500890","https://openalex.org/W2107775880","https://openalex.org/W2123068491","https://openalex.org/W2557644083","https://openalex.org/W4417004720","https://openalex.org/W2988807594","https://openalex.org/W163170924","https://openalex.org/W2535733854","https://openalex.org/W2065325944","https://openalex.org/W2097878023"],"abstract_inverted_index":{"Myeloma":[0],"is":[1,48,65,121,169],"associated":[2,123],"with":[3,114,124],"suppression":[4],"of":[5,15,32,51,58,69,71,96,139,146],"osteoblastogenesis,":[6],"consequentially":[7],"resulting":[8],"in":[9,100,118,132],"increased":[10,33,109,166],"osteoclast":[11],"activity":[12,35,168],"and":[13,29,54,64,78,104,164,178,183],"induction":[14],"typical":[16],"osteolytic":[17],"bone":[18,98,176],"disease.":[19],"The":[20],"molecular":[21,149],"mechanisms":[22,150],"by":[23,75,79],"which":[24],"myeloma":[25,37,62,76,101,126,140,157,175,181],"cells":[26,60,77,81,141,158],"suppress":[27,159],"osteoblastogenesis":[28,47,73,160],"the":[30,67,83,137],"consequences":[31],"osteoblast":[34,110,167],"on":[36],"cell":[38],"growth":[39,138],"have":[40],"been":[41],"partially":[42],"delineated":[43],"only":[44],"recently.":[45],"Reduced":[46],"a":[49,115,143,170],"consequence":[50],"abnormal":[52],"properties":[53],"impaired":[55],"osteogenic":[56],"potential":[57,148],"osteoprogenitor":[59],"from":[61,142],"patients":[63],"also":[66],"result":[68],"production":[70],"multiple":[72],"inhibitors":[74],"microenvironmental":[80],"within":[82],"myelomatous":[84],"bone.":[85],"Nevertheless,":[86],"novel":[87],"osteoblast-activating":[88],"agents":[89,107],"(e.g.":[90],"proteasome":[91],"inhibitor":[92],"bortezomib)":[93],"are":[94,151],"capable":[95],"inducing":[97],"formation":[99],"animal":[102],"models":[103],"clinically.":[105],"These":[106,153],"induce":[108],"activity,":[111],"often":[112],"coupled":[113],"concomitant":[116],"reduction":[117],"osteoclastogenesis,":[119],"that":[120,156,165],"strongly":[122],"reduced":[125],"tumor":[127],"burden.":[128],"In":[129],"vitro,":[130],"osteoblasts,":[131],"contrast":[133],"to":[134,161,173],"osteoclasts,":[135],"attenuate":[136],"large":[144],"subset":[145],"patients;":[147],"discussed.":[152],"studies":[154],"suggest":[155],"their":[162],"advantage":[163],"promising":[171],"approach":[172],"treat":[174],"disease":[177],"simultaneously":[179],"control":[180],"development":[182],"progression.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2104958967","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
